Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.
about
The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.The role of the urologist in the prevention and early detection of cardiovascular disease.Testosterone and cardiovascular risk.Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormonesTestosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.Testosterone and the metabolic syndrome.Neuroendocrine factors alter host defense by modulating immune function.Effects of transdermal testosterone treatment on inflammatory markers in elderly males.Testosterone therapy and prostate cancer.The role of testosterone in type 2 diabetes and metabolic syndrome in men.Do androgens play any role in the physical frailty of ageing men?Hormonal effects on blood vessels.Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?Role of olfactory reactions, nociception, and immunoendocrine shifts in addictive disorders.Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.The Effects of Testosterone Deficiency and Its Replacement on Inflammatory Markers in Rats: A Pilot Study.Relationship between insulin and hypogonadism in men with metabolic syndrome.Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial.Testosterone replacement therapy in hypogonadal men is associated with increased expression of LAMP-2 (CD107b) by circulating monocytes and dendritic cells.Administration of testosterone to elderly hypogonadal men with Crohn's disease improves their Crohn's Disease Activity Index: a pilot study
P2860
Q34097510-2952C04C-9454-4A66-963B-35870926B9D5Q34108216-F17DE59F-1854-439E-AB06-4437382594FAQ34332054-D5FEF9B4-5905-44C8-BEB1-D4C68E4FB2C4Q34590954-FA6EAED4-36A5-4741-BC1A-08C706A10568Q35810322-E89D6E39-5744-4FB8-B58C-EDEBEB0F7F3DQ36327973-C56F24DA-050D-4659-9E61-C9441BC00699Q36990011-B53F0496-1547-41C9-845A-B3C6B88A38E8Q37234333-4840AA88-C1A3-43D5-A788-4D51FEFA8392Q37531045-788DD725-16B3-415E-B2F1-B4FE891E7B50Q37686143-DB90D80A-982A-4720-AD70-C3C88A5E3413Q37781089-FFA80ACD-E0EE-4FEC-85D1-112C11CBE428Q37980611-6176AB8D-D288-43E1-B221-10D788ECCBC8Q38071012-3139E25A-D785-4B9A-9AB7-A51A55DE3C1EQ38637350-805A7D01-D464-4B38-B471-71D33D186906Q39401091-3F91EDD8-82DA-4EF6-B018-20EE369985A8Q41371729-9D7B8D40-8F44-4FD3-890A-448868B6DA15Q43176618-C317FF0B-9408-4811-9FCB-CF808D0F4B5AQ50017410-04A00B2F-DB7E-46EC-A550-DE22DB2C3B52Q51246104-166CEC62-0A36-4586-ADEE-0802657A13B8Q54792823-0CF9267F-C46A-41D1-9439-BEC4871CED8BQ57338570-B7F01648-5316-4500-829F-23E1BA31FAC5
P2860
Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Androgen-replacement therapy d ...... h partial androgen deficiency.
@ast
Androgen-replacement therapy d ...... h partial androgen deficiency.
@en
Androgen-replacement therapy d ...... h partial androgen deficiency.
@nl
type
label
Androgen-replacement therapy d ...... h partial androgen deficiency.
@ast
Androgen-replacement therapy d ...... h partial androgen deficiency.
@en
Androgen-replacement therapy d ...... h partial androgen deficiency.
@nl
prefLabel
Androgen-replacement therapy d ...... h partial androgen deficiency.
@ast
Androgen-replacement therapy d ...... h partial androgen deficiency.
@en
Androgen-replacement therapy d ...... h partial androgen deficiency.
@nl
P2093
P356
P1476
Androgen-replacement therapy d ...... h partial androgen deficiency.
@en
P2093
P304
P356
10.1677/JOE.1.06779
P407
P577
2006-06-01T00:00:00Z